Related references
Note: Only part of the references are listed.MicroRNA-375 Is Downregulated in Gastric Carcinomas and Regulates Cell Survival by Targeting PDK1 and 14-3-3ζ
Yoshiyuki Tsukamoto et al.
CANCER RESEARCH (2010)
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival
Thomas Greither et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L. Dalgliesh et al.
NATURE (2010)
MicroRNA-210 Regulates Mitochondrial Free Radical Response to Hypoxia and Krebs Cycle in Cancer Cells by Targeting Iron Sulfur Cluster Protein ISCU
Elena Favaro et al.
PLOS ONE (2010)
Centrosome amplification is correlated with ploidy divergence, but not with MYCN amplification, in neuroblastoma tumors
Daisuke Fukushi et al.
CANCER GENETICS AND CYTOGENETICS (2009)
MicroRNA Regulation of DNA Repair Gene Expression in Hypoxic Stress
Meredith E. Crosby et al.
CANCER RESEARCH (2009)
MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2
Stephen Y. Chan et al.
CELL METABOLISM (2009)
A mechanism linking extra centrosomes to chromosomal instability
Neil J. Ganem et al.
NATURE (2009)
Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis
Andrew J. Holland et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Emerging roles of E2Fs in cancer: an exit from cell cycle control
Hui-Zi Chen et al.
NATURE REVIEWS CANCER (2009)
hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer
Carme Camps et al.
CLINICAL CANCER RESEARCH (2008)
MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3
Pasquale Fasanaro et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c
C. Nakada et al.
JOURNAL OF PATHOLOGY (2008)
High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma
T. Yoshimoto et al.
JOURNAL OF PATHOLOGY (2007)
A microRNA signature of hypoxia
Ritu Kulshreshtha et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Renal cancer cells lacking hypoxia inducible factor (HIF)-1 alpha expression maintain vascular endothelial growth factor expression through HIF-2 alpha
Toshiaki Shinojima et al.
CARCINOGENESIS (2007)
Analysis of the cellular centrosome in fine-needle aspirations of the breast
Hui-Qin Guo et al.
BREAST CANCER RESEARCH (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes
O. A. Kent et al.
ONCOGENE (2006)
Centrosome abnormalities are frequently observed in non-small-cell lung cancer and are associated with aneuploidy and cyclin E overexpression
M. K. Koutsami et al.
JOURNAL OF PATHOLOGY (2006)
Novel treatments for metastatic renal cell carcinoma
DJ van Spronsen et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Inactivation of E2F3 results in centrosome amplification
HI Saavedra et al.
CANCER CELL (2003)
Carp, a cardiac ankyrin-repeated protein, and its new homologue, Arpp, are differentially expressed in heart, skeletal muscle, and rhabdomyosarcomas
N Ishiguro et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Centrosome amplification drives chromosomal instability in breast tumor development
WL Lingle et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
P Schraml et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
